Regulatory news and experts insights.

The identification of endocrine disruptors (EDs) has become a major public health and environmental concern worldwide. EDs are chemical substances capable of interfering with the hormonal system, leading to adverse effects on both humans and wildlife. Monitoring and assessing these substances is essential to protect human health, particularly among vulnerable populations such as pregnant women, children, and wild species. To this end, the U.S. Environmental Protection Agen

Les substances per- et polyfluoroalkylées (PFAS) font l’objet d’une attention croissante des autorités européennes en raison de leur persistance, bioaccumulation et toxicité.Dans ce contexte, le secteur des produits phytopharmaceutiques (PPP) est désormais scruté de près à travers le rapport de restriction de l’Annexe XV de l’ECHA. Ce rapport indique que les substances actives utilisées dans les PPP, les produits biocides et les produits médicinaux se distinguent chimiquemen

At CEHTRA, regulatory expertise goes beyond compliance. Our strength lies in a human-driven, client-focused approach supported by collective intelligence and responsible scientific commitment.

Discover Cehtrawatch, the digital regulatory monitoring tool that keeps your business compliant with controlled updates and no software installation needed.

Learn what an endocrine disruptor is, how EDs are identified in the EU, and the regulatory criteria used under CLP, biocides, and pesticides. Discover how CEHTRA supports ED assessment and classification.